Beyfortus (Nirsevimab) 101: Is This RSV Shot Right for Your Baby?

• 2025

  Log in to bookmark this resource.

  Log in
• Brandon Hunter

---

Access Resources

• LectureEN
• Ask aRCie About This Resource

About

This video is about Beyfortus (Nirsevimab), a new immunization for RSV approved by the FDA in 2023. It describes how RSV affects children and the benefits of Beyfortus, which reduces severe infections without serious side effects. The speaker explains that while most kids recover from RSV, some need hospitalization. Studies show Beyfortus lowers doctor visits and hospital stays due to RSV. It's recommended for infants under 8 months unless their mother received another vaccine during pregnancy. The speaker believes this immunization could greatly reduce severe cases of RSV in children, making it very beneficial overall.

---

Tags

Focus Area: Infectious Disease

Audience: Families & Children

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Asthma; Bronchiolitis, Viral; Immunization; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination

Institutions: ItsBranMD

---

More like this

Understanding Parvovirus B19, Symptoms, Prevention, and Concerns 2024 · Bee Kind Pediatrics Sepsis and Kids: A Public Information Forum with Experts from Perth Children's Hospital 2024 · Perth Children's Hospital Protect Your Family and Community: Essential Tips for Staying Healthy During Respiratory Illness Season 2024 · Pediatric Pandemic Network (PPN)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---